NCT07470723

The ORIGIN-FH Study

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-02-14Est. Completion: 2029-02-14

Enrollment target: 70 participants

Locations

Contact

Heterozygous Familial Hypercholesterolemia (HeFH)

A phase 1/2, two-part trial consisting of an open label dose-escalation part and a randomized, double blind, placebo-con…

Charlestown, AustraliaEst. completion Jun 2029

Heterozygous Familial Hypercholesterolemia (HeFH)

This study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with het…

Wilmington, United StatesEst. completion Dec 4, 2033

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.